-
-
-
-
-
-
-
Vyant Bio Announces Rescheduled Investor Conference Call and Webcast for the Second Quarter and First Half of 2022
-
-
-
-
-
-
-
Vyant Bio (VYNT) Reports Q1 Loss from Cont. Operations of $0.15
-
-
-
-
-
-
-
Vyant Bio (VYNT) Issues Letter to Shareholders
-
-
-
-
-
-
-
Vyant Bio Reports First Quarter 2021 Results and Provides Strategic Business Update
-
1,197,295 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

